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Background: To evaluate the clinical usefulness of estimated glomerular filtration rate (eGFR) divided by functional
renal volume (FRV) measured by three-dimensional image reconstruction (eGFR/FRV) for the prediction of functional
outcomes after nephrectomy.
Methods: Eighty-three patients who underwent nephrectomy were enrolled. The FRV of each patient was
measured before surgery. Preoperative medical information on proteinuria, blood pressure, blood glucose level,
body mass index (BMI), hemoglobin level and serum cholesterol level were also obtained. We evaluated the
relationships between eGFR/FRV and each of these parameters before surgery. We also assessed the potential
relationship between eGFR/FRV and the 3-year postoperative eGFR. Stepwise multiple regression analyses were
conducted to elucidate independent factors.
Results: The median FRV and eGFR were 310.15 cm3 and 79.0 ml/min/1.73 m2 before surgery, respectively. The
correlation between FRV and eGFR was statistically significant (r = 0.465, P < 0.001). The median eGFR/FRV was
0.24 ml/min/1.73 m2/cm3. Stepwise multiple regression analysis showed that the independent parameters (multiple
correlation coefficient, r = 0.389, P = 0.031) associated with eGFR/FRV were proteinuria, BMI, age and hypertension.
Proteinuria was statistically associated with eGFR/FRV, and the independent parameters (multiple correlation
coefficient, r = 0.694, P < 0.001) associated with the 3-year postoperative eGFR were age, BMI and eGFR/FRV. The
eGFR/FRV was statistically associated with the 3-year postoperative eGFR (r = 0.559, P < 0.001).
Conclusion: The present results demonstrated that patients with proteinuria are expected to have a lower
eGFR/FRV than those without proteinuria. The present study also supports the notion that eGFR/FRV is the primary
determinant of the long-term functional outcome after nephrectomy. It should be taken into consideration that
patients with a low eGFR/FRV may develop chronic kidney disease after nephrectomy.
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Most patients who are newly diagnosed with renal cell
carcinoma (RCC) are usually treated surgically. Recently,
nephron sparing surgery (NSS) is considered to be as
curative for early stage RCC as radical nephrectomy
(RN) [1] and is becoming a standard therapy for small
RCC. Several groups have reported that RN increases* Correspondence: yukinari46@nyc.odn.ne.jp
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article, unless otherwise stated.the risk for adverse renal and cardiovascular morbidity
[2-4]. NSS also resulted in cancer-specific survival equiva-
lent to RN [5]. However, RN remains the most common
surgery for small renal tumors [6]. From the perspective
of the prevention of postoperative renal insufficiency, the
prediction of postoperative renal function is definitely an
important issue in patients who undergo renal surgery.
Accurate prediction of postoperative renal function should
be considered before renal surgery is performed.
We have previously reported that postoperative renal
function can accurately be predicted before surgery bytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Hosokawa et al. World Journal of Surgical Oncology 2014, 12:59 Page 2 of 6
http://www.wjso.com/content/12/1/59using both the preoperative serum creatinine level (sCr)
and the functional renal volume (FRV), which is esti-
mated by three-dimensional reconstructed software and
diagnostic images (computed tomography (CT) scan and
magnetic resonance imaging (MRI)) [7]. This prediction
was not only available for patients who underwent RN,
but also for those who underwent NSS. Although FRV
showed a significant correlation with sCr and creatinine
clearance (CCr) [7], the absolute values of sCr and CCr
varied between patients with similar FRV. This finding
may be caused by the difference in patients’ age or gen-
der, and comorbidities such as hypertension, cardiovas-
cular disease, hyperlipidemia, diabetes mellitus, renal
insufficiency, or other conditions.
The meaning of renal function per FRV in renal sur-
gery is unknown. It would be informative and meaning-
ful to clarify the clinical significance of renal function
per FRV in association with perioperative and long-term
management after renal surgery, the evaluation of renal
function in healthy individuals, and the assessment of




The institutional review board approved this study, and
informed consent was obtained from all patients after
explaining the aim and methods of this study.
Patient selection
Eighty-three patients who consecutively underwent neph-
rectomy or donor nephrectomy, and for whom preoperative
FRV was calculated using three-dimensional reconstruction
software between 2006 and 2008 at Nara Medical Univer-
sity and its affiliated hospital were enrolled. These patients
consisted of 44 men and 39 women. Their mean age was
60.1 years (median 60.0 years, range 26 to 89 years). Of all
of these patients, 45 underwent RN for RCC, 9 underwent
nephroureterectomy for upper urinary tract carcinoma, and
29 underwent donor nephrectomy.
Preoperative and postoperative renal function
assessment
To calculate FRV, enhanced CT scans and MRI images
were input into the computer program. We used a dy-
namic image of the arterial phase to determine the func-
tional renal parenchyma. For each diagnostic image, the
renal parenchyma was traced by erasing the neighboring
organs, fat tissue, muscles, and collecting system which
are not of interest using the computer mouse. The
traced outlines of the renal parenchyma in all the images
were combined to automatically reconstruct a three-
dimensional image. The FRV was estimated by integral
calculation software (MU1128, developed by Y YamazakiY, and commercially unavailable). The estimated glom-
erular filtration rate (eGFR) was adopted as the renal
function. The eGFR was calculated from sCr and age
using the following equation: eGFR (ml/min/1.73 m2) =
194 × sCr -1.094 × age -0.287 (× 0.739, for females). This
equation was revised for the Japanese population from
the original equation of the Modification of Diet in
Renal Disease (MDRD) study by the Japanese Society of
Nephrology [8].
We evaluated the correlation between preoperative
eGFR and FRV in all the patients. The renal function per
FRV was calculated as eGFR divided by FRV (eGFR/FRV).
To elucidate the parameters that correlated significantly
with eGFR/FRV, the following parameters were tested:
age, gender, anemia, body mass index (BMI), hyperten-
sion, proteinuria, hyperlipidemia, and diabetes mellitus.
The cut-off value of hyperlipidemia was either a serum
cholesterol level of 220 mg/dl or greater or a serum trigly-
ceride level of 150 mg/dl or greater [9]. If patients were
receiving medication for hyperlipidemia, they were catego-
rized as hyperlipidemia regardless of the cut-off value. Pa-
tients with a fasting blood sugar level of 126 mg/dl or
greater, or an HbA1c level of 6.5% or greater, were catego-
rized as having diabetes mellitus according to the defin-
ition by the Japan Diabetes Society [10]. Patients who
were receiving medication for diabetes mellitus were also
defined as having diabetes mellitus. The cut-off value of
proteinuria was defined as a positive result on the paper
strip test. Patients who showed a systolic blood pressure
of 140 mmHg or greater or a diastolic blood pressure of
90 mmHg or greater were categorized as having hyperten-
sion. This stratification was defined as first-degree hyper-
tension by the Japanese Society of Hypertension [11].
Patients who were receiving medication for hypertension
were also defined as having hypertension. Patients were
followed for 3 years or longer.
Statistical analysis
Spearman’s rank correlation test was used to assess the
correlation between eGFR and FRV. The Mann–Whitney
U test was used to compare eGFR/FRV between patients
with and without preoperative comorbidities. Stepwise
multiple regression analysis was used to elucidate the sig-
nificant parameters correlating to eGFR/FRV (step-up
method: Fin = Fout = 2.0). Stepwise multiple regression
analysis was also used to investigate parameters independ-
ently determining the 3-year postoperative eGFR. All stat-
istical analyses were carried out using SPSS 17.0 J (SPSS
Inc., Chicago, IL, USA). P < 0.05 was regarded as statisti-
cally significant in all statistical tests.
Results
Table 1 shows the patients’ characteristics. The median
values of the preoperative FRV and the eGFR were
Table 1 Characteristics of 83 patients with functional
renal volume measurements
Parameter
Men age (years) 60.1 (range 26–89; median 60.0)
Gender (male/female) 44/39
Mean BMI (kg/m2) 23.2 ± 4.1 (range 17.2-45.0;
median 22.8)
HT (yes/no) 51/32 (under treatment n = 25)
Diabetes (yes/no) 15/68 (under treatment n = 6)
Hyperlipidemia (yes/no) 39/44 (under treatment n = 7)
Anemia (yes/no) 18/65
Proteinuria (yes/no) 13/70
eGFR (ml/min/1.73 m2) 77.5 ± 21.0 (range 19.0-125.7;
median 79.0)
eGFR (ml/min/1.73 m2)/FRV (cm3) 0.25 ± 0.06 (range 0.10-0.40;
median 0.24)
BMI, body mass index; eGFR, estimated glomerular filtration rate; FRV,
functional renal volume; HT, hypertension.
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garding concurrent diseases, 61.4% of the patients had
hypertension, the most common concurrent disease, and
15.7% of the patients had proteinuria, the least frequent
concurrent disease. Although there was a significant
correlation between FRV and eGFR by Spearman’s rank
correlation test (r = 0.465, P < 0.001) (Figure 1), the cor-
relation coefficient was moderate. Indeed, the distribu-
tion of eGFR varied between individuals. There was a
difference in eGFR of approximately 80 ml/min/1.73 m2
in patients with similar FRV.
The mean eGFR/FRV was 0.25 ml/min per 1.73 m2/cm3
(SD 0.06, median 0.24). Each value of eGFR/FRV strati-
fied by clinical parameters was investigated. There were
significant differences in eGFR/FRV depending on gender
(male = 0.22 ml/min per 1.73 m2/cm3 versus female =






















Figure 1 Significant correlation between estimated glomerular filtrati
three-dimensional image reconstruction (r = 0.465, P < 0.001). Note th= 0.23 ml/min per 1.73 m2/cm3 versus no = 0.27 ml/min
per 1.73 m2/cm3, P = 0.033), proteinuria (yes = 0.20 ml/min
per 1.73 m2/cm3 versus no = 0.26 ml/min per 1.73 m2/cm3,
P < 0.001) and BMI (≥22 kg/m2 = 0.22 ml/min per
1.73 m2/cm3 versus <22 kg/m2 = 0.28 ml/min per
1.73 m2/cm3, P < 0.001), while there were no significant
differences between diabetes, hyperlipidemia and anemia.
The independent parameters associated with eGFR/FRV
were proteinuria, BMI, age, and hypertension (multiple
correlation coefficient, r = 0.389, P = 0.031). Of these four
parameters, proteinuria is the only significant parameter
in the multiple regression analysis (standardized partial re-
gression coefficient −0.253, P = 0.042).
At the last follow up, 10 patients had died of cancer
and 17 patients had been lost to follow-up. The 3-year
postoperative median eGFR was 50.1 ml/min/1.73 m2.
The median follow-up period was 36.0 months (mean
27.1 months). There was a significant decrease in eGFR
at 1 month after nephrectomy, but no further significant
changes thereafter. There was no significant relationship
between the reduction rate of the 1-month postoperative
eGFR and eGFR/FRV (r = −0.211, P = 0.119).
The patient characteristics divided by an eGFR/FRV
cutoff at 0.24 are presented in Table 2. This cutoff value
is defined as the point with the most significant (Mann–
Whitney test) split between preoperative eGFR/FRV and
the 3-year postoperative eGFR. Comparison of the re-
duction rate between the preoperative eGFR and the 1-
month postoperative eGFR did not show a significant
difference between the eGFR/FRV ≥0.24 and the eGFR/
FRV <0.24 groups (P = 0.4355). Compared to low eGFR/
FRV (<0.24), high eGFR/FRV (≥0.24) were younger, had
lower BMI and high eGFR. There were also significant
differences in gender, diabetes and proteinuria, while
there were no significant differences between hyperten-
sion, hyperlipidemia and anemia. Patients under 60 years,
those without hypertension or hyperlipidemia and those00 400 500 600
FRV (cm3)
r=0.465, p<0.001
on rate (eGFR) and funtional renal volume (FRV) estimated by
at the distribution of eGFR varies between individuals with similar FRV.
Table 2 Characteristics of 83 patients divided by an
eGFR/FRV cutoff at 0.24





Age (years) 64.7 ± 9.6 55.8 ± 14.3 0.002
Gender (male/female) 26/14 18/25 0.035
BMI (kg/m2) 24.3 ± 4.8 22.2 ± 3.1 0.027
HT (yes/no) 28/12 23/20 0.123
Diabetes (yes/no) 11/29 4/39 0.031
Hyperlipidemia (yes/no) 21/19 18/25 0.332
Anemia (yes/no) 10/30 8/35 0.480
Proteinuria (yes/no) 13/27 0/43 <0.001
eGFR (ml/min/1.73 m2) 64.1 ± 17.0 89.9 ± 16.2 <0.001
Donor nephrectomy (yes/no) 10/30 19/24 0.067
BMI, body mass index; eGFR, estimated glomerular filtration rate; FRV,
functional renal volume; HT, hypertension.
Table 3 Multiple regression analysis of factors
determining 3-year postoperative eGFR
Parameters Standardized partial
regression coefficient
t value P value
Age −0.376 −3.590 0.001
Gender (female versus male) * * 0.787
BMI (<22 kg/m2 versus
≥22 kg/m2)
0.165 1.622 0.111
HT (no versus yes) * * 0.891
Diabetes (no versus yes) * * 0.797
Hyperlipidemia (no versus yes) * * 0.967
Anemia (no versus yes) * * 0.923
Proteinura (no versus yes) * * 0.796
eGFR/FRV 0.489 4.588 <0.001
*Factors that were not selected by means of stepwise multiple
regression analysis.
Multiple correlation coefficient, r = 0.694, P < 0.001. BMI, body mass index;
eGFR, estimated glomerular filtration rate; FRV, functional renal volume;
HT, hypertension.
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superior preoperative renal function. Patients with an
eGFR/FRV of ≥0.24 retained significantly better renal
function than those with an eGFR/FRV of <0.24 at 3 years
postoperatively (Figure 2). Gender, BMI, diabetes mellitus,
anemia and proteinuria did not have a significant influ-
ence. The independent parameters associated with 3-year
postoperative eGFR are age, BMI and eGFR/FRV (multiple
correlation coefficient, r = 0.694, P < 0.001). On multivariate
analysis, age and eGFR/FRV were the significant parame-
ters (Table 3). The preoperative eGFR/FRV significantly
correlated with the 3-year postoperative eGFR (r = 0.559,


















< 0.24 64.14±17.01 (n=43) 42.01±12.23 (n=
0.24 89.93±16.16 (n=40) 56.39±13.79 (n=
<0.001
<0.001
Figure 2 Estimated glomerular filtration rate (eGFR) change of the co
by an eGFR/FRV cutoff at 0.24. Patients with an eGFR/FRV of ≥0.24 had
<0.24 at 3 years postoperatively. FRV, functional real volume.Discussion
The deterioration of renal function after renal surgery
(for example, nephrectomy, NSS and nephrouretectomy)
is a major concern. Recent observations suggest that RN
significantly increases the risk of de novo chronic renal
insufficiency compared with PN [2,3]. It was also noted
that a decreased eGFR is associated with an increased
risk of death, cardiovascular events and hospitalization
[2-4]. However, RN is commonly performed for RCC
in the USA [6]. The prediction of postoperative renal
function is a meaningful approach to reduce the risk of
postoperative renal insufficiency. Many reports have<0.001<0.001
3 years1 year
43) 42.25±14.44 (n=38) 41.18±13.28 (n=27)





ntralateral kidney after nephrectomy in the two groups divided
significantly better renal function than those with an eGFR/FRV of
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RN and NSS [3,12-14].
In the USA, it is common to use the MDRD equation
to calculate eGFR [15]. Accurate calculation of eGFR for
each ethnic group requires modification of the equation.
Therefore, the equation was revised for the Japanese
population by using age, gender, and serum creatinine
and the original equation of the MDRD Study by the
Japanese Society of Nephrology [8]. In the present study,
we used this equation to calculate eGFR. We have
already reported that FRV can be calculated by diagnos-
tic images (CT scan and MRI) and three-dimensional
reconstruction software. We have also elucidated that
the postoperative renal function and FRV can be pre-
dicted preoperatively by using preoperative renal func-
tion and FRV [7]. Gong and colleagues reported that
CT-estimated FRV strongly correlated positively with
renal function and correlated inversely with age [16].
However, no one has studied eGFR/FRV. Our results in-
dicate that the distribution of eGFR varied between indi-
viduals with similar FRV, but there was a moderate
correlation between eGFR and FRV. The multiple re-
gression analysis revealed that proteinuria is the only
parameter that influences the eGFR/FRV. This result
may reveal that glomerular function influences eGFR/
FRV. It is well known that proteinuria is a risk factor for
renal insufficiency. Imai and colleagues reported that pa-
tients with positive proteinuria showed a significant de-
crease in eGFR of 5 ml/min/1.73 m2 in all generations
between 40 and 80 years based on the 2005 Japanese
annual health check program [17]. They concluded that
proteinuria is strongly associated with renal insuffi-
ciency. They also reported that the decreasing rate of
renal function in patients with positive proteinuria is
around twice as high as that in patients without protein-
uria in a longitudinal study using the Japanese annual
health check program [18]. James and colleagues also re-
ported that the risk factor of acute renal failure is
strongly associated with eGFR and proteinuria in a co-
hort study in approximately 920,000 adults residing in
Alberta, Canada [19]. Taken together, it seems that posi-
tive proteinuria is a risk factor for renal insufficiency
after nephrectomy, as well as a risk factor for mortality
in the normal population.
We also attempted simultaneous analysis of changes in
eGFR after nephrectomy. In our series, eGFR/FRV was an
independent predictor of the 3-year postoperative renal
function and showed significantly correlation with the
GFR at 3 years after nephrectomy (P < 0.001). Lindeman
and Goldman reported that the age-related decrease in
GFR in individuals with no specific renal disease was at-
tributable to an involutional process leading to glomerular
atrophy [20]. The differences in the eGFR/FRV in individ-
uals could reflect glomerular function in individuals.Moreover, preoperative eGFR/FRV influenced postopera-
tive renal function. This present study was focused on
eGFR/FRV. However, both eGFR and FRV per se are also
reported as a significant predictor for eGFR change of the
contralateral kidney after nephrectomy [21]. We have also
reported this issue [7]. Under these investigations, the re-
lationship between FRV and renal function might be inter-
esting. In other words, patients with the same renal
function show different FRV. Consequently, we had the
idea of using renal function per unit volume (eGFR/FRV).
There are several limitations to the present study.
Firstly, the number of patients was small and the observa-
tion period was short. Moreover, 10 patients had died of
cancer and 17 patients had been lost to the last follow-up.
We must take into consideration the influence of these
patients. Secondly, the definition of hypertension included
patients who were already being treated with antihyper-
tensive medication. It is controversial to combine patients
who are treated with such medications as angiotensin II
receptor blockers and untreated patients in the same co-
hort [22]. Thirdly, it is more complicated to handle
patients with diabetes mellitus than normal patients, be-
cause diabetic patients in their 40s showed higher eGFR
than those with a normal blood glucose level due to
hyperfiltration [17]. Finally, our series included RCC,
upper urinary tract carcinoma, and living kidney donors.
It is generally noted that patients with RCC already had a
decreased eGFR [23,24]. Whether there was hydronephro-
sis or not before surgery may influence the postoperative
renal function.
Our present study and our previous report [7] reveal
that there was a significant correlation between FRV and
eGFR. Proteinuria was an independent factor that influ-
enced the eGFR/FRV. Patients who undergo nephrec-
tomy with an eGFR/FRV of <0.24 should be closely
observed for the development of renal insufficiency.
Conclusions
It is obvious that preoperative FRV and renal function
play important factors in postoperative renal function.
Further studies on the clinical usefulness of the eGFR/
FRV measurement are necessary to elucidate the signifi-
cant risk factors for the development of renal insuffi-
ciency after nephrectomy. This will allow us to identify
those who should be on a strict follow-up schedule and
who should receive daily life guidance to avoid renal in-
sufficiency after nephrectomy. The scheduled monitor-
ing of renal function and integration of the feedback
analysis is expected to serve as a predictive tool for the
development of medium- and long-term renal function.
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